Skip to main content

Table 3 Composite endpoint (all-cause death, non-fatal myocardial infarction (MI), percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) or non-fatal stroke) and total number of cardiovascular events in patients with and without elevated cardiac Troponin T (< 14 ng/L) one year after myocardial infarction/percutaneous coronary intervention/coronary artery bypass grafting

From: Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial

 

Elevated cardiac Troponin T

Low cardiac Troponin T

p*

n = 241

n = 1037

 

Composite endpoint

93 (38.6)

268 (25.8)

 < 0.001

Death (%)

25 (10.4)

33 (3.2)

 < 0.001

Myocardial infarction (%)

16 (6.6)

47 (4.5)

0.18

Percutaneous coronary intervention (%)

57 (23.7)

205 (19.8)

0.18

Coronary artery bypass grafting (%)

5 (2.1)

8 (0.8)

0.07

Stroke (%)

18 (7.5)

32 (3.1)

0.002

  1. Mean follow-up time: 5.7 (SD 2.7) years
  2. *p-values referring to differences in proportions between group with or without elevated Troponin T